MENU
LRMR
AS OF
Nov 13, 04:59 PM (EDT)
Price
$3.29
Change
-$0.08 (-2.37%)
Capitalization
281.59M
124 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
LRMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Larimar Therapeutics (LRMR) Earnings Date & Reports

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform... Show more

A.I. Advisor
published Earnings

LRMR is expected to report earnings to fall 32.10% to -41 cents per share on March 18

Larimar Therapeutics LRMR Stock Earnings Reports
Q4'25
Est.
$-0.41
Q3'25
Missed
by $0.20
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.11
Q4'24
Missed
by $0.14
The last earnings report on November 05 showed earnings per share of -61 cents, missing the estimate of -41 cents. With 1.29M shares outstanding, the current market capitalization sits at 281.59M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
LRMR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LRMR showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for LRMR
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com